IGPS

Kelonia Therapeutics, Inc.

Application Filed: 2022-08-24
Trademark Application Details
Trademark Logo IGPS

Mark For: IGPS™ trademark registration is intended to cover the categories of pharmaceutical, medical and clinical preparations for use in cell and gene therapy; pharmaceutical, medical and clinical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; Cell and gene therapy vectors for treatment of cancer and genetic diseases; therapeutic preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; t-cells for medical and therapeutic use; cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer and genetic diseases; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cancer and genetic diseases.

Status

2022-08-27 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number97562899
Mark Literal ElementsIGPS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTrademark, Service Mark
Current LocationNEW APPLICATION PROCESSING 2022-08-27
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameSyed M. Abedi
Attorney Docket Number930207.20010

Timeline

2022-08-24Application Filed
2022-08-27Location: NEW APPLICATION PROCESSING
2022-08-27Status: Live/Pending
2022-08-27Status: New application will be assigned to an examining attorney approximately 6 months after filing date.
2022-08-27Transaction Date

Trademark Parties (Applicants & Owners)

Party: Kelonia Therapeutics, Inc.
AddressFifth Floor 5 Channel Center Boston, MASSACHUSETTS UNITED STATES 02210
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

Application2022-08-24
Drawing2022-08-24

Attorney of Record

SYED M. ABEDI
SEED IP LAW GROUP LLP
701 FIFTH AVENUE
SUITE 5400
SEATTLE, WA 98104

Good, Services, and Codes

International Codes:5
U.S. Codes:005,006,018,044,046,051,052
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0051Pharmaceutical, medical and clinical preparations for use in cell and gene therapy; pharmaceutical, medical and clinical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; Cell and gene therapy vectors for treatment of cancer and genetic diseases; therapeutic preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; t-cells for medical and therapeutic use; cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer and genetic diseases; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cancer and genetic diseases
GS0421Scientific and medical research services in the field of cell and gene therapies; Scientific and medical research services in the field of cell and gene therapies using engineered viral vectors

Trademark Filing History

DescriptionDateProceeding Number
NEW APPLICATION ENTERED IN TRAM2022-08-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed